Abstract: The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.

Abstract: The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.

Abstract: A method of preparing a transparent polymer material includes i) obtaining composite nanoparticles having mineral nanoparticles at least partially coated with at least one monomer and/or at least one polymer suitable for promoting physicochemical interactions at the interface between the mineral nanoparticles and a thermoplastic polycarbonate matrix, the mineral nanoparticles being surface-modified by the monomer and/or the polymer, either directly by grafting or directly by adsorption of the monomer and/or polymer onto the surface of the mineral nanoparticles; or via a coupling agent selected from a chlorosilane or an organosilane including a functional group that is capable of reacting by a radical pathway. The composite nanoparticles obtained in step i) are mixed with the thermoplastic polycarbonate matrix in the molten state to obtain the transparent polymer material.

Abstract: The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.

Abstract: A method of preparing a transparent polymer material includes i) obtaining composite nanoparticles having mineral nanoparticles at least partially coated with at least one monomer and/or at least one polymer suitable for promoting physicochemical interactions at the interface between the mineral nanoparticles and a thermoplastic polycarbonate matrix, the mineral nanoparticles being surface-modified by the monomer and/or the polymer, either directly by grafting or directly by adsorption of the monomer and/or polymer onto the surface of the mineral nanoparticles; or via a coupling agent selected from a chlorosilane or an organosilane including a functional group that is capable of reacting by a radical pathway. The composite nanoparticles obtained in step i) are mixed with the thermoplastic polycarbonate matrix in the molten state to obtain the transparent polymer material.

Abstract: The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals or heat when excited by X rays, and to the uses thereof in health, particularly human. The inventive particles comprise an inorganic-based, and optionally organic-based, nucleus and can be activated in vivo, in order to label or alter cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or diagnostic compositions containing same.